J9281 Mitomycin Pyelocalyceal Instillation - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Mitomycin Pyelocalyceal Instillation

Brand Name:

Jelmyto

Strength:

1mg

HCPCS:

J9281

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antitumor Antibiotic

Minor Drug Class:

Alkylating Agent/Mitomycin

Oral (Y/N):

No

FDA Approval Year:

2020

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2021

CMS Discontinuation Date:

Status:

In Use